Skip to main content

Government’s contracts with Randox Laboratories Ltd


At the start of the pandemic Government had to rapidly create high volume COVID-19 testing capacity, but the National Audit Office (NAO) has found that, even taking the exceptional circumstances into account, “the documentation of the decision-making process for such large contracts was inadequate”, and Government did “not document key decisions adequately when awarding a contract to Randox Laboratories Ltd (Randox) for testing services”.

The gaps in the audit trail mean the NAO was “not able to provide positive assurance in the normal way, but has not seen any evidence that the government’s contracts with Randox were awarded improperly”.

The Committee will question senior officials at DHSC and UK Health and Security Agency.

If you have evidence on these issues please submit it here by 6 pm Wednesday 11 May 2022.

This inquiry is no longer accepting evidence

The deadline for submissions was Wednesday 11 May 2022.

Upcoming events

View all events

No upcoming events scheduled

Contact us

  • Email:
  • Phone: 020 7219 5776 (general enquiries) | 020 7219 8480 (media enquiries)
  • Address: Public Accounts Committee, House of Commons, London, SW1A 0AA